<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04604106</url>
  </required_header>
  <id_info>
    <org_study_id>NL71873.018.19</org_study_id>
    <nct_id>NCT04604106</nct_id>
  </id_info>
  <brief_title>General Anesthesia Exposure and Neurodevelopmental Outcome in Pediatrics</brief_title>
  <acronym>GAP</acronym>
  <official_title>General Anesthesia Exposure and Neurodevelopmental Outcome in Pediatrics</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the impact of different levels of anesthesia exposure on children's&#xD;
      neurocognitive development and evaluates the concurrent validity of different methods that&#xD;
      assess neurodevelopmental outcome.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The US Food and Drug Administration (FDA) recently released an official warning regarding the&#xD;
      potentially harmful impact of repeated and prolonged (more than three hours) general&#xD;
      anesthesia on the child's brain. The potential impact of anesthesia highlights the importance&#xD;
      of remediating the need for repeated and prolonged surgery with accompanying anesthesia&#xD;
      exposure in a time of cerebral vulnerability and if possible, delay exposure to avoid&#xD;
      potentially preventable harm. Therefore, it is crucial to better understand the impact of&#xD;
      (different durations and frequencies of) anesthesia exposure on neurodevelopment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 21, 2020</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Neurocognitive development as measured using eye-tracking metrics</measure>
    <time_frame>At the age of 12 months (± four weeks)</time_frame>
    <description>Neurocognitive development as measured using eye-tracking metrics</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Conventional measures of neurocognitive development (Ages &amp; Stages Questionnaire and Bayley Scales of Infant Development )</measure>
    <time_frame>At the age of 12 months (± four weeks)</time_frame>
    <description>Neurocognitive development as measured using the Ages &amp; Stages Questionnaire and Bayley Scales of Infant Development</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total anesthesia time.</measure>
    <time_frame>At the age of 12 months (± four weeks)</time_frame>
    <description>Surgery and anesthesia time will be recorded by the (fellow) surgeon performing the operation(s). When multiple procedures are carried out, durations will be combined and these results will be retrieved during analysis of the data.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Anesthesia</condition>
  <condition>Infant Development</condition>
  <condition>Anesthesia; Adverse Effect</condition>
  <arm_group>
    <arm_group_label>Patient group</arm_group_label>
    <description>Infant aged 12 months (± four weeks) with a history of general anesthesia exposure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy subject group</arm_group_label>
    <description>Infant aged 12 months (± four weeks) without a history of general anesthesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Eyetracker</intervention_name>
    <description>Eye-tracking is an objective, non-invasive method and particularly suited to assess neurodevelopmental outcome in infants.</description>
    <arm_group_label>Healthy subject group</arm_group_label>
    <arm_group_label>Patient group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Ages &amp; Stages questionnaire</intervention_name>
    <description>The Ages &amp; Stages Questionnaire is a conventional instrument used to measure developmental outcome in infants.</description>
    <arm_group_label>Healthy subject group</arm_group_label>
    <arm_group_label>Patient group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Bayley Scale of Infant Development</intervention_name>
    <description>The Bayley Scale of Infant Development is a conventional instrument used to measure developmental outcome in infants.</description>
    <arm_group_label>Healthy subject group</arm_group_label>
    <arm_group_label>Patient group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        At the outpatient clinic of the department of pediatric surgery, children (&lt; 12 months old)&#xD;
        who are scheduled for or already underwent a single short, long or repetitive general&#xD;
        anesthesia will be identified by the (fellow) pediatric surgeon. Parents/caretakers will be&#xD;
        asked to participate in this study by the (fellow) surgeon who will ask informed consent.&#xD;
        Healthy controls exist of eligible acquaintances and children that will be recruited via&#xD;
        child health care centres by a member of the research team&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age 12 months (± four weeks) with a history of general anesthesia exposure (patient&#xD;
             group) or without a history of general anesthesia (healthy controls)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Children with comorbid conditions affecting structure and/or function of the central&#xD;
             nervous system (e.g. premature birth) will be excluded from participation in this&#xD;
             study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>11 Months</minimum_age>
    <maximum_age>13 Months</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J.P.M. Derikx, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Amsterdam UMC, locatie AMC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>J. Oosterlaan, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Amsterdam UMC, locatie AMC</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Sanne Maat, MD</last_name>
    <phone>0031650100868</phone>
    <email>s.c.maat@amsterdamumc.nl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Amsterdam UMC, locatie AMC</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord-Holland</state>
        <zip>1105AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>J.P.M. Derikx, MD, PhD</last_name>
      <phone>+31205665693</phone>
      <email>j.derikx@amsterdamumc.nl</email>
    </contact>
    <contact_backup>
      <last_name>Jaap Oosterlaan, Prof.</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 21, 2020</study_first_submitted>
  <study_first_submitted_qc>October 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 27, 2020</study_first_posted>
  <last_update_submitted>November 8, 2021</last_update_submitted>
  <last_update_submitted_qc>November 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)</investigator_affiliation>
    <investigator_full_name>Sanne Maat</investigator_full_name>
    <investigator_title>Dr. J.P.M. Derikx</investigator_title>
  </responsible_party>
  <keyword>Anesthesiology</keyword>
  <keyword>Neuropsychological test</keyword>
  <keyword>Infant neurodevelopmental disorders</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

